Pharmaceuticals

Psoriatic Arthritis Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the psoriatic arthritis treatment market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Psoriatic Arthritis Treatment Market by the end of 2030?

The psoriatic arthritis treatment market size has experienced substantial growth in recent years. It is forecast to expand from $13.17 billion in 2025 to $14.36 billion in 2026, driven by a compound annual growth rate (CAGR) of 9.0%. The market’s historical growth can be attributed to several factors, including the limited availability of advanced therapies, continued reliance on conventional NSAIDs and DMARDs, the increasing prevalence of psoriatic arthritis, growing patient awareness, and the expansion of hospital and retail pharmacy infrastructure.

The psoriatic arthritis treatment market size is anticipated to experience robust expansion in the coming years. It is projected to expand to $20.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is attributable to factors such as the development of interleukin inhibitors and JAK inhibitors, the increasing adoption of biologics, the progress of personalized medicine approaches, the rising use of telemedicine for managing chronic diseases, and increased government and insurance backing for psoriatic arthritis treatment. Significant trends expected during this period include the growing acceptance of biologics and targeted synthetic DMARDs, enhanced awareness of early diagnosis and management of psoriatic arthritis, the evolution of personalized treatment strategies for both joint and skin symptoms, the broadening of hospital and specialty pharmacy distribution channels, and the integration of telemedicine and remote monitoring for psoriatic arthritis patients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

What Drivers Are Shaping Future Opportunities In The Psoriatic Arthritis Treatment Market?

The expansion in healthcare spending is projected to propel the growth of the psoriatic arthritis treatment market going forward. Healthcare spending, also recognized as healthcare expenditure, pertains to the financial resources designated to support the provision of healthcare services, products, and programs within a specific country, region, or healthcare system. This spending aids the diagnostic process by financing medical appointments, laboratory tests, and imaging studies. Individuals with PsA frequently undergo a comprehensive evaluation to confirm their diagnosis, determine the extent of joint involvement, and assess any associated comorbidities. For instance, in December 2024, the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, reported that U.S. health care expenditures in 2023 rose by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, this increase in healthcare spending is driving the growth of the psoriatic arthritis treatment market.

Which Segment Groups Are Influencing The Psoriatic Arthritis Treatment Market?

The psoriatic arthritis treatment market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs

3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics

4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors

What Upcoming Trends Are Likely To Define The Future Path Of The Psoriatic Arthritis Treatment Market?

Prominent companies operating within the psoriatic arthritis treatment market are obtaining authorizations for new drugs, such as Cosentyx, to bolster their market profitability. Cosentyx is a medication utilized in the management of autoimmune diseases including non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. As an example, in October 2023, Novartis, a pharmaceutical company based in Switzerland, disclosed that the Food and Drug Administration had granted approval for its latest drug, Cosentyx. This drug operates as a human interleukin-17A antagonist, functioning by preventing the activation of a protein identified as IL-17A, which serves to diminish potential patient adverse reactions like edema, discomfort, and skin rashes. Cosentyx has been demonstrated to effectively manage the symptoms of psoriatic arthritis, with its effects potentially commencing in as little as three weeks, providing relief for various symptoms such as joint pain and tenderness, back discomfort, and skin problems.

Who Are The Core Companies Influencing Trends In The Psoriatic Arthritis Treatment Market?

Major companies operating in the psoriatic arthritis treatment market are AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Which Regions Are Projected To Dominate The Psoriatic Arthritis Treatment Market In The Coming Years?

North America was the largest region in the psoriatic arthritis treatment market in 2025. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Psoriatic Arthritis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3458&type=smp

Browse Through More Reports Similar to the Global Psoriatic Arthritis Treatment Market 2026, By The Business Research Company

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Microbiome Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report

Orthobiologics Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795